Clinical Trial Spotlight: Asthma Research Study
Researchers are conducting a study to test the safety of a type of asthma medication called formoterol, a component of Symbicort, when it is taken in combination with inhaled corticosteroids to find out if the addition of an inhaled corticosteroid, such as budesonide, reduces the increased risk of asthma-related hospitalizations and death from formoterol.
They are looking for adolescents and adults, aged 12 years and older, who have been diagnosed with asthma. Participants will be compensated for study-related time and travel.
For more information, contact the research coordinator at 513-558-5795 or 513-558-0924.
Tags
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.